Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISCO: Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery
NCT07766109Phase 4Not yet recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, empagliflozin in heart failure (HF), sponsored by Centre hospitalier universitaire de Toulouse. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dapagliflozinempagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07766109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07766109.